XML 46 R33.htm IDEA: XBRL DOCUMENT v3.21.2
Revenue (Details)
3 Months Ended 9 Months Ended
Sep. 30, 2021
USD ($)
pharmacy
Sep. 30, 2020
USD ($)
Sep. 30, 2021
USD ($)
pharmacy
Sep. 30, 2020
USD ($)
Dec. 31, 2020
USD ($)
CONCENTRATION          
Number of specialty pharmacies | pharmacy 2   2    
Allowance for doubtful accounts $ 7,200,000   $ 7,200,000   $ 5,300,000
Change in estimate of uncollectible (percent)     0.50%    
Change in revenue recognized due to 0.5% change in uncollectible percentage     $ 300,000    
Increase (decrease) to revenues 33,718,000 $ 31,020,000 106,025,000 $ 77,712,000  
COVID-19 potential impacts          
CONCENTRATION          
Allowance related to the potential impacts of COVID-19 (less than)         $ 100,000
Additional allowance recorded     0    
Accounting Standards Update 2014-09 | Difference between Revenue Guidance in Effect before and after Topic 606          
CONCENTRATION          
Increase (decrease) to revenues $ 153,000 $ 8,000 $ (125,000) $ 695,000